Why It Matters

The Senate HELP Committee hearing represented a critical inflection point for America’s organ transplantation system. Despite reaching 48,000 transplants in 2024, thousands die annually awaiting organs while demand vastly outpaces supply.

Key challenges driving reform:

  • Documented Racial Disparities: A May 2025 CMS study found 21 of 58 organ procurement organizations showed significantly lower transplant rates for Black recipients; 18 showed disparities for Asian Americans and Pacific Islanders.
  • Federal Structural Overhaul: The Health Resources and Services Administration’s OPTN Modernization Initiative aims to break up nearly four decades of single-contractor management by United Network for Organ Sharing (UNOS), moving to a competitive multi-vendor model.
  • Research Funding Threat: Proposed NIH budget cuts of roughly 40% jeopardize innovation at academic centers like University of Wisconsin-Madison, which developed the groundbreaking UW Solution for organ preservation.

The intense lobbying—UNOS spending $180,000, Organize Action Network spending $200,000, and Southwest Transplant Alliance spending $120,000—underscores how much turns on this hearing’s outcome.

Broader Context

The U.S. organ transplantation system faces its biggest overhaul in four decades. The Organ Procurement and Transplantation Network (OPTN) has operated under a single federal contract held by UNOS. HRSA’s modernization initiative aims to break up this monopoly through a competitive, multi-vendor model.

Persistent challenges include chronic organ shortages, system inefficiency, and geographic inequities. Performance varies widely across 57 nonprofit Organ Procurement Organizations, with location heavily influencing transplant chances.

Senator Tammy Baldwin has warned that proposed NIH funding cuts threaten critical transplant research, specifically highlighting University of Wisconsin-Madison’s "UW Solution" for organ preservation. Senator Ed Markey’s connection to experimental xenotransplantation procedures suggests committee focus on innovative solutions.

The Agenda

The hearing will feature testimony from key transplantation system stakeholders, including representatives from UNOS, the current sole OPTN contractor facing transition to multi-vendor competition.

Organize Action Network, a vocal reform advocate, will present perspectives on systemic improvements. Southwest Transplant Alliance Inc., one of 57 regional Organ Procurement Organizations, will testify on procurement regulations and access challenges.

Additional participants include healthcare providers, transplant centers, patient advocacy groups, research institutions, and potentially HRSA officials overseeing modernization implementation.

Between The Lines

Senator Tammy Baldwin (D-WI) has emerged as a vocal advocate for preserving federal research funding. She specifically highlighted threats to University of Wisconsin-Madison, warning that proposed cuts eliminating approximately $65 million would "devastate critical medical research." Baldwin will likely press witnesses on how modernized OPTN structure supports academic research partnerships.

Senator Ed Markey (D-MA) has been associated with experimental xenotransplantation procedures, suggesting he may focus on facilitating cutting-edge alternatives to address donor shortages.

Competitive Landscape

Three major stakeholder groups have spent over $500,000 lobbying Congress on transplantation policy over nine months:

UNOS committed $180,000 across 2025 quarters, deploying five lobbyists through Tarplin, Downs & Young LLC on "federal budget issues and organ donation, procurement and transplant matters."

Organize Action Network spent $200,000 advocating for systemic OPTN reform, retaining eight lobbyists at Farragut Partners LLP focusing on "organ donation system and organ procurement transplantation network issues."

Southwest Transplant Alliance invested $120,000 through Todd Strategy Group on "organ procurement regulations and increasing access to organ transplant."

The Bottom Line

The OPTN Modernization Initiative is dismantling decades of single-contractor management while recent research documents persistent racial disparities across procurement organizations. Despite record 2024 transplant volume, systemic inefficiencies remain. Federal funding pressures threaten innovation research as the system transitions to competitive multi-vendor management.

For more detailed insights access Legis1. Request a demo today!

Spot something wrong? Report an issue with this article